Three Bridge Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$203K Buy
+405
New +$194K 0.05% 85
2026
Q1
Sell
-525
Closed -$304K 90
2025
Q4
$304K Hold
525
0.08% 73
2025
Q3
$255K Sell
525
-26
-5% -$12.1K 0.07% 77
2025
Q2
$224K Buy
551
+26
+5% +$10.9K 0.06% 117
2025
Q1
$261K Hold
525
0.09% 75
2024
Q4
$273K Buy
+525
New +$289K 0.1% 78
2024
Q3
Sell
-376
Closed -$208K 92
2024
Q2
$208K Sell
376
-225
-37% -$129K 0.08% 87
2024
Q1
$350K Hold
601
0.14% 72
2023
Q4
$319K Hold
601
0.11% 74
2023
Q3
$304K Hold
601
0.13% 70
2023
Q2
$314K Sell
601
-25
-4% -$13.5K 0.13% 71
2023
Q1
$361K Hold
626
0.17% 64
2022
Q4
$345K Buy
626
+76
+14% +$40.3K 0.18% 57
2022
Q3
$279K Hold
550
0.14% 71
2022
Q2
$299K Hold
550
0.15% 71
2022
Q1
$325K Buy
+550
New +$316K 0.09% 70

Other funds holding TMO

Three Bridge Wealth Advisors's TMO Position: Q2 2026 in Review

Three Bridge Wealth Advisors opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 405 shares worth $203K. The stake represents 0.05% of the portfolio and ranks #85 among its holdings. This is a return to the name: Three Bridge Wealth Advisors previously reported a position in TMO as recently as Q4 2025.

Three Bridge Wealth Advisors first reported a position in TMO in Q1 2022 and has held it in 16 quarters since. The position peaked at $361K in Q1 2023. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Three Bridge Wealth Advisors held 405 shares of Thermo Fisher Scientific worth $203K as of Q2 2026.
  • Thermo Fisher Scientific was a new Three Bridge Wealth Advisors position in Q2 2026.
  • Thermo Fisher Scientific made up 0.05% of Three Bridge Wealth Advisors's portfolio in Q2 2026, its #85 holding.
  • Three Bridge Wealth Advisors first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 16 quarters since.
  • Three Bridge Wealth Advisors's Thermo Fisher Scientific position peaked at $361K in Q1 2023.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Three Bridge Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.